Edgar Haber
#82,974
Most Influential Person Now
Edgar Haber's AcademicInfluence.com Rankings
Edgar Haberphilosophy Degrees
Philosophy
#2914
World Rank
#4833
Historical Rank
Logic
#851
World Rank
#1405
Historical Rank
Edgar Haberbiology Degrees
Biology
#3479
World Rank
#5317
Historical Rank
Endocrinology
#14
World Rank
#17
Historical Rank
Biochemistry
#331
World Rank
#401
Historical Rank
Download Badge
Philosophy Biology
Edgar Haber's Degrees
- PhD Biochemistry University of California, San Francisco
- Doctorate Medicine University of California, San Francisco
Why Is Edgar Haber Influential?
(Suggest an Edit or Addition)Edgar Haber's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. (1969) (2359)
- Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. (1988) (1461)
- Binding of immunogenic peptides to Ia histocompatibility molecules (1985) (1175)
- The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. (1961) (1053)
- The heart and cardiovascular system (1986) (894)
- Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. (1994) (834)
- Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. (1969) (625)
- Studies on the reduction and re-formation of protein disulfide bonds. (1961) (460)
- Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. (1990) (347)
- Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. (1976) (338)
- Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. (1970) (334)
- Digitalis intoxication. A prospective clinical study with serum level correlations. (1971) (322)
- Digitalis intoxication. (1971) (283)
- The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. (1976) (283)
- Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). (1986) (281)
- Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. (1983) (271)
- Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. (1982) (266)
- The renin-angiotensin system (first of two parts). (1974) (266)
- Induction of Apoptosis by Pyrrolidinedithiocarbamate and N-Acetylcysteine in Vascular Smooth Muscle Cells (*) (1996) (254)
- The application of 0.1 M quadrol to the microsequence of proteins and the sequence of tryptic peptides. (1975) (246)
- Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin. (1970) (241)
- Protein engineering of single-chain Fv analogs and fusion proteins. (1991) (223)
- Antigenic competition at the level of peptide-Ia binding. (1986) (208)
- Immunologic basis of transplant-associated arteriosclerosis. (1996) (206)
- The Role of the Renin‐Angiotensin‐Aldosterone System in Cardiovascular Homeostasis in Normal Human Subjects (1976) (205)
- Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. (1993) (204)
- Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. (1986) (203)
- Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. (1996) (202)
- Side-chain interactions governing the pairing of half-cystine residues in ribonuclease. (1962) (184)
- Structure of antibody hypervariable loops reproduced by a conformational search algorithm (1988) (184)
- Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. (1990) (182)
- Cloning and Functional Analysis of the Promoter for KDR/flk-1, a Receptor for Vascular Endothelial Growth Factor(*) (1995) (177)
- Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells. (1996) (173)
- Innovative approaches to plasminogen activator therapy. (1989) (172)
- Specificity of Localization of Myosin‐specific Antibody Fragments in Experimental Myocardial Infarction: Histologic, Histochemical, Autoradiographic and Scintigraphic Studies (1979) (171)
- Renin synthesis by canine aortic smooth muscle cells in culture. (1982) (169)
- Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. (1982) (168)
- Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction. (1984) (167)
- Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. (1985) (163)
- Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. (1987) (161)
- Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. (1980) (161)
- Inhibition of Growth and p21 ras Methylation in Vascular Endothelial Cells by Homocysteine but Not Cysteine* (1997) (160)
- Antibody-directed urokinase: a specific fibrinolytic agent. (1985) (155)
- Characterization of the renin-aldosterone system in decompensated cirrhosis. (1977) (152)
- Localization of cardiac myosin-specific antibody in myocardial infarction. (1976) (152)
- Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. (1987) (150)
- The Cell Membrane (1984) (149)
- Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. (1982) (145)
- Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. (1996) (142)
- Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon. (1979) (133)
- The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin. (1971) (129)
- Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo. (1987) (129)
- Inhibition of Angiotensin Conversion in Experimental Renovascular Hypertension (1972) (126)
- A radioimmunoassay for bradykinin in plasma and synovial fluid. (1969) (123)
- Progesterone inhibits arterial smooth muscle cell proliferation (1997) (123)
- Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. (1970) (122)
- Preservation of antimyosin antibody activity after covalent coupling to liposomes. (1979) (121)
- Molecular anatomy of the antibody binding site. (1983) (118)
- George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis. (1976) (118)
- Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. (1984) (114)
- Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines. (1978) (113)
- High-affinity monoclonal antibodies to the cardiac glycoside, digoxin. (1982) (112)
- Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. (1996) (111)
- The renin-angiotensin system (second of two parts). (1974) (110)
- Reduced transplant arteriosclerosis in plasminogen-deficient mice. (1998) (110)
- 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity. (1993) (110)
- Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus. (1976) (109)
- Inhibition of angiotensin conversion and prevention of renal hypertension. (1975) (107)
- Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. (1993) (105)
- Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. (1998) (103)
- Structural features of gamma-immunoglobulin, antibody, and their fragments. Circular dichroism studies. (1968) (103)
- Arrest of endotoxin-induced hypotension by transforming growth factor beta1. (1996) (100)
- Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle. (1973) (100)
- A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. (1990) (100)
- Radioimmunoassay of Angiotensin in Human Plasma (1967) (99)
- Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. (1997) (97)
- Murine model of accelerated transplant arteriosclerosis. (1994) (96)
- RECOVERY OF ANTIGENIC SPECIFICITY AFTER DENATURATION AND COMPLETE REDUCTION OF DISULFIDES IN A PAPAIN FRAGMENT OF ANTIBODY. (1964) (94)
- Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension. (1980) (93)
- Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule. (1985) (93)
- Construction and expression of a recombinant antibody-targeted plasminogen activator. (1987) (92)
- Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. (1987) (91)
- The search for a hypothalamic Na+,K+-ATPase inhibitor. (1987) (88)
- Regeneration of enzyme activity by air oxidation of reduced subtilisin-modified ribonuclease. (1961) (87)
- An antiidiotypic antibody that recognizes the beta-adrenergic receptor. (1982) (87)
- Inhibition of angiotensin-converting enzyme for diagnosis of renal-artery stenosis. (1978) (86)
- Molecular Cloning and Characterization of SmLIM, a Developmentally Regulated LIM Protein Preferentially Expressed in Aortic Smooth Muscle Cells (*) (1996) (85)
- Aortic Carboxypeptidase-like Protein, a Novel Protein with Discoidin and Carboxypeptidase-like Domains, Is Up-regulated during Vascular Smooth Muscle Cell Differentiation* (1998) (84)
- Vascular Endothelial Growth Factor Induces Heparin-binding Epidermal Growth Factor-like Growth Factor in Vascular Endothelial Cells* (1998) (82)
- Experimental Myocardial Infarct Imaging following Intravenous Administration of Iodine-131 Labeled Antibody (Fab')2 Fragments Specific for Cardiac Myosin (1978) (80)
- SYNTHESIS OF ANTIGENIC BRANCH-CHAIN COPOLYMERS OF ANGIOTENSIN AND POLY-L-LYSINE. (1965) (77)
- Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs. (1977) (77)
- Complete purification of dog renal renin. (1979) (76)
- Binding and structural diversity among high-affinity monoclonal anti-digoxin antibodies. (1985) (75)
- Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography. (1972) (75)
- Platelet‐Targeted Fibrinolysis Enhances Clot Lysis and Inhibits Platelet Aggregation (1991) (75)
- Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family. (1996) (74)
- Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen. (1982) (74)
- Competitive inhibitors of renin. (1973) (72)
- Degradation of E2A Proteins through a Ubiquitin-conjugating Enzyme, UbcE2A* (1997) (71)
- Studies with the radioimmunoassay for angiotensin II, and its application to measurement of renin activity. (1969) (71)
- Structural invariants of antigen binding: comparison of immunoglobulin VL-VH and VL-VL domain dimers. (1985) (70)
- Identification of high risk subsets of acute myocardial infarction (1978) (70)
- Inhibition of clot-bound alpha 2-antiplasmin enhances in vivo thrombolysis. (1990) (69)
- Construction of a model for the three-dimensional structure of human renal renin. (1985) (69)
- Early Imaging of Experimental Myocardial Infarction by Intracoronary Administration of 1311-Labelled Anticardiac Myosin (Fab')2 Fragments (1978) (68)
- Competitive inhibitors of renin. Inhibitors effective at physiological pH. (1975) (68)
- Digitalis (fourth of four parts). (1973) (67)
- Embryonic expression suggests an important role for CRP2/SmLIM in the developing cardiovascular system. (1998) (66)
- Suppression of plasma renin and plasma aldosterone during water immersion in normal man. (1975) (66)
- Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin (Fab')2. (1983) (66)
- Renin-specific antibody for study of cardiovascular homeostasis. (1980) (65)
- Localization of Radiolabeled Cardiac Myosin‐Specific Antibody in Myocardial Infarcts: Comparison with Technetium‐99m Stannous Pyrophosphate (1977) (65)
- Renal arterial pressure, renin secretion, and blood pressure control in trained dogs. (1973) (64)
- Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis (1996) (64)
- Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro. (1988) (63)
- Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator. (1990) (63)
- A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor. (1971) (62)
- Regulation of CD44 Gene Expression by the Proinflammatory Cytokine Interleukin-1β in Vascular Smooth Muscle Cells* (1998) (58)
- Antibody-directed fibrinolysis. An antibody specific for both fibrin and tissue plasminogen activator. (1989) (58)
- Clinical value of the radioimmunoassay of the digitalis glycosides. (1973) (57)
- Location of antigenic epitopes on antibody molecules. (1986) (57)
- Nuclear Protein Interactions with the Human KDR/flk-1 Promoter in Vivo (1997) (57)
- Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies. (1988) (57)
- Modifications in the Heterogeneity of the Antibody Response (1967) (56)
- Digitalis (third of four parts). (1973) (55)
- Digitalis (second of four parts). (1973) (55)
- Antibodies to type III and type VIII pneumococcal polysaccharides: evidence for restricted structural heterogeneity in hyperimmunized rabbits. (1970) (55)
- Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. (1996) (54)
- Mechanism of Pulmonary Conversion of Anglotensin II to Angiotensin II in the Dog (1971) (54)
- Relation of immediate and delayed thallium-201 distribution to localization of iodine-125 antimyosin antibody in acute experimental myocardial infarction. (1983) (53)
- Identification of an angiotensin receptor in rabbit renomedullary interstitial cells in tissue culture. Correlation with prostaglandin biosynthesis. (1980) (51)
- Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin. (1990) (51)
- Cellular mechanisms of impaired adrenergic responsiveness in neonatal dogs. (1981) (50)
- Gamma heavy chain disease--an expanding clinical and laboratory spectrum. (1973) (49)
- Characterization of an antibody-urokinase conjugate. A plasminogen activator targeted to fibrin. (1987) (49)
- Specific cleavage between variable and constant domains of rabbit antibody light chains by dilute acid hydrolysis. (1972) (48)
- Detection of Serum Cardiac Myosin Light Chains in Acute Experimental Myocardial Infarction: Radioimmunoassay of Cardiac Myosin Light Chains (1978) (48)
- Nature of vitamin B 12 binding. II. Steric orientation of vitamin B 12 on binding and number of combining sites of human intrinsic factor and the transcobalamins. (1971) (48)
- Production of antibody against bradykinin: demonstration of specificity by complement fixation and radio-immunoassay. (1966) (47)
- Modulation of antibody affinity by a non‐contact residue (1993) (47)
- Characterization of the mUBC9-binding Sites Required for E2A Protein Degradation* (1999) (47)
- Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin. (1994) (47)
- A large form of renin from normal human kidney. (1978) (46)
- Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments. (1984) (46)
- Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1. (1990) (45)
- The Role of Free Radical‐Mediated Processes in Oxygen‐Related Damage in Cultured Murine Myocardial Cells (1985) (45)
- Amino acid sequence analysis with methyl isothiocyanate. Resolution of the methylthiohydantoins by gas-liquid partition chromatography. (1970) (44)
- Effects of pH and enzyme inhibitors on apparent generation of angiotensin I in human plasma. (1974) (43)
- Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding. (1987) (42)
- Plasminogen Activators: The Old and the New (1989) (41)
- Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice. (1997) (41)
- A direct microassay for aldosterone in plasma extracts. (1978) (41)
- Increased specificity in human cardiac-myosin radioimmunoassay utilizing two monoclonal antibodies in a double sandwich assay. (1982) (41)
- Thrombolysis by a fibrin-specific antibody Fab'-urokinase conjugate. (1987) (41)
- Fab fragments of digoxin-specific antibodies used to reverse ventricular fibrillation induced by digoxin ingestion in a child. (1982) (40)
- Icterus and febrile reactions in response to isonicotinic acid hydrazine; report of two cases and review of the literature. (1959) (40)
- Interferon-γ-mediated Inhibition of Cyclin A Gene Transcription Is Independent of Individual cis-Acting Elements in the Cyclin A Promoter* (1999) (40)
- Activation of blood clotting in patients with systemic lupus erythematosus. Relationship to disease activity. (1978) (38)
- Recombinant antibodies possessing novel effector functions. (1989) (38)
- Specificity of antigenic recognition of antibody heavy chain (1966) (37)
- Immunological reversal of the effects of digoxin. (1977) (37)
- Antibodies in human diagnosis and therapy (1977) (37)
- A substrate analog inhibitor of renin that is effective in vivo. (1980) (37)
- Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis. (1999) (36)
- Interference with immunoassays of angiotensin I and II by proteins in human plasma. (1971) (36)
- Imaging the Rejecting Heart: In Vivo Detection of Major Histocompatibility Complex Class II Antigen Induction (1992) (36)
- The renin-angiotensin system and hypertension. (1979) (36)
- Structure of the antibody combining site. I. Hapten stabilization of antibody conformation. (1967) (36)
- Nature of vitamin B 12 binding. I. Covalent coupling of hydroxocobalamin to soluble and insoluble carriers. (1971) (35)
- Antibody to bradykinin: effect of carrier and method of coupling on specificity and affinity. (1968) (35)
- Early Detection of Rejection and Assessment of Cyclosporine Therapy by 111In Antimyosin Imaging in Mouse Heart Allografts (1991) (34)
- Hemodynamic effects of a competitive renin inhibitory peptide in humans: evidence for multiple mechanisms of action. (1983) (33)
- Radio immunoassay employing gel filtration. (1965) (33)
- HOMOGENEOUS ELICITED ANTIBODIES: INDUCTION, CHARACTERIZATION, ISOLATION, AND STRUCTURE * (1971) (33)
- Diversity of light chain variable region sequences among rabbit antibodies elicited by the same antigens. (1975) (32)
- The use of an internal reference amino acid for the evaluation of reactions in solid-phase peptide synthesis. (1980) (32)
- On the specificity of human renin. Studies with peptide inhibitors. (1976) (31)
- Variation in the primary structure of antibodies during the course of immunization. (1971) (31)
- Antibodies as specific renin inhibitors: studies with polyclonal and monoclonal antibodies and Fab fragments. (1983) (31)
- Polarization of fluorescence as a measure of antigen-antibody interaction. (1962) (31)
- Massive digoxin poisoning treated with Fab fragments of digoxin-specific antibodies. (1982) (31)
- Production of stable anti-digoxin Fv in Escherichia coli. (1992) (31)
- Altered hapten recognition by two anti-digoxin hybridoma variants due to variable region point mutations. (1991) (30)
- Donor MHC and adhesion molecules in transplant arteriosclerosis. (1999) (30)
- Quantitative solid-phase Edman degradation for evaluation of extended solid-phase peptide synthesis. (1981) (30)
- Amino acid sequence of rabbit pneumococcal antibody. I. Light-chain cysteine-containing peptides. (1972) (29)
- Recent developments in pathophysiologic studies of the renin-angiotensin system. (1969) (29)
- Bispecific Monoclonal Antibodies Produced by Somatic Cell Fusion Increase the Potency of Tissue Plasminogen Activator (1990) (29)
- Changes in intrinsic circular dichroism of several homogeneous anti-type 3 pneumococcal antibodies on binding of a small hapten. (1972) (29)
- A simplified radioimmunoassay for plasma aldosterone employing an antibody of unique specificity. (1974) (29)
- Evolution of the immune response to type 3 and 8 pneumococcal polysaccharides. (1973) (28)
- The role of the renin--angiotensin--aldosterone system in cardiovascular homeostasis in normal man. (1975) (28)
- Renin--angiotensin antagonists and the regulation of blood pressure. (1976) (28)
- Structural requirements for binding to antibody of sequence variants of bradykinin. (1967) (28)
- Protein Hal: partial deletion of a " " immunoglobulin gene(s) and apparent reinitiation at an internal AUG codon. (1973) (28)
- Properties of structurally restricted antibody to type VIII pneumococcal polysaccharide. (1970) (27)
- Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides. (1987) (27)
- Antibodies to Pneumococcal Polysaccharides: Relation between Binding and Electrophoretic Heterogeneity (1968) (27)
- Synthesis of an antigenic copolymer of angiotensin and succinylated poly-L-lysine. (1967) (27)
- Peptides: an analytical method for their resolution by polyacrylamide gel electrophoresis applicable to a wide range of sizes and solubilities. (1975) (27)
- An antibody specific for the propranolol binding site of cardiac muscle. (1979) (26)
- Current techniques for serum or plasma digitalis assay and their potential clinical application. (1970) (26)
- Design of rat renin inhibitory peptides. (1988) (26)
- Antibody binding sites. (1996) (26)
- Purification of human intrinsic factor by affinity chromatography. (1973) (26)
- The synthesis and antigenic properties of a macromolecular peptide of defined sequence bearing the dinitrophenol hapten. (1967) (26)
- An active derivative of rabbit antibody light chain composed of the constant and the variable domains held together only by a native disulfide bond. (1972) (26)
- Clones of human lymphoblastoid cell lines producing antibody to tetanus toxoid. (1978) (26)
- Antigenicity of myohemerythrin. (1987) (25)
- The Polymyositis-Scleroderma Autoantigen Interacts with the Helix-Loop-Helix Proteins E12 and E47* (1997) (24)
- Problems in identification of the beta-adrenergic receptor. (1976) (24)
- Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10. (1993) (24)
- Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting. (1997) (24)
- Antibodies in vivo. (1982) (24)
- Detection of experimental myocarditis by monoclonal antimyosin antibody, Fab fragment. (1989) (23)
- Origins of antibody diversity: insight gained from amino acid sequence studies of elicited antibodies. (1977) (23)
- Induction of fibrin-specific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites. (1983) (23)
- A bispecific antibody enhances the fibrinolytic potency of single-chain urokinase. (1990) (23)
- Static accessibility model of protein antigenicity: the case of scorpion neurotoxin. (1986) (22)
- Isolation and characterization of structurally homogeneous antibodies from antipneumococcal sera. (1970) (22)
- The preparation of human kininogen and the elicitation of antibody for use in a radial immuno-diffusion assay. (1970) (21)
- Specific Inhibitors of Renin (1980) (21)
- Selectivity of angiotensin II antisera. (1983) (21)
- Engineered Antibodies as Pharmacological Tools (1992) (21)
- Inhibition of factor XIII activation by an anti-peptide monoclonal antibody. (1991) (21)
- Antibodies of restricted heterogeneity for structural study. (1970) (21)
- Comparison of the suppressive effects of water immersion and saline administration on renin-aldosterone in normal man. (1979) (21)
- Letter: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20,881. (1974) (20)
- In vivo diagnostic and therapeutic uses of monoclonal antibodies in cardiology. (1986) (20)
- Anti-alprenolol antibodies in the rabbit. A new probe for the study of beta-adrenergic receptor interaction. (1980) (20)
- Restricted rabbit antibodies: amino acid sequences of rabbit H chains of allotype a1, a2, and a3 in the region 80 to 94. (1973) (20)
- Affinity purification of cardiac adenylate cyclase: dependence on prior hydrophobic resolution. (1978) (20)
- The relationship between antigenic complexity and heterogeneity in the antibody response. (1969) (20)
- The production and characterization of specific antibodies to aldosterone. (1971) (19)
- Transformation by simian virus 40 of spleen cells from a hyperimmune rabbit: evidence for synthesis of immunoglobulin by the transformed cells. (1974) (19)
- Is Renin a Factor in the Etiology of Essential Hypertension? (1983) (19)
- Purification of human renal renin. (1978) (19)
- Demonstration of the hydrophilic character of adenylate cyclase following hydrophobic resolution on immobilized alkyl residues. Critical role of alkyl chain length. (1977) (19)
- Purification of hog renin by affinity chromatography using the synthetic competitive inhibitor (D-Leu6)octapeptide. (1975) (19)
- Reversible Renovascular Hypertension and Renal Arterial Pressure 1 (1974) (19)
- THE EFFECT ON ANTIGENIC SPECIFICITY OF CHANGES IN THE MOLECULAR STRUCTURE OF RIBONUCLEASE. (1963) (18)
- Structural requirements for binding of bradykinin to antibody. II. Studies with bradykinin fragments. (1968) (18)
- Inhibitors of renin and their utility in physiologic studies. (1979) (18)
- Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genes. (1990) (18)
- Fractionation of antibodies to the pneumococcal polysaccharides by affinity chromatography. (1973) (17)
- Why renin inhibitors? (1989) (17)
- Evidence for the beta-adrenergic receptor regulation of membrane-bound catechol-O-methyltransferase activity in myocardium. (1979) (16)
- The interdomain disulfide bond of a homogeneous rabbit pneumococcal antibody light chain. (1975) (16)
- Crystallization of the Fab fragment of a monoclonal anti-digoxin antibody and its complex with digoxin. (1983) (16)
- Identification of renin and renin-like enzymes in rat brain by a renin-specific antibody. (1980) (16)
- Contribution of a single heavy chain residue to specificity of an anti‐digoxin monoclonal antibody (1994) (16)
- Structural requirements for binding of bradykinin to antibody. 3. The effect of carrier on antibody specificity. (1969) (16)
- A simplified radioimmunoassay for physiologically active angiotensin peptides [(1-8) octa- and (2-8) heptapeptides]. (1984) (15)
- Antibodies and digitalis: the modern revolution in the use of an ancient drug. (1985) (15)
- Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production. (1986) (15)
- Monoclonal Antibodies Binding Renal Renin (1981) (14)
- Industry and the university (1996) (14)
- The First Sir George Pickering Memorial Lecture Which Inhibitors will Give us True Insight into What Renin Really Does? (1984) (14)
- Continuously Proliferating Human Cell Lines Synthesizing Antibody of Predetermined Specificity (1980) (14)
- Peptide inhibitors of renin in cardiovascular studies. (1983) (14)
- Antibody-directed fibrinolysis: a bispecific (Fab')2 that binds to fibrin and tissue plasminogen activator. (1990) (14)
- Sulfur protection with the 3-nitro-2-pyridine sulfenyl group in solid-phase peptide synthesis. (2009) (14)
- Extensive degradation of antibody by pepsin. (1967) (14)
- Detection and quantification of myocardial cell death: application of monoclonal antibodies specific for cardiac myosin. (1982) (14)
- Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis. (1991) (13)
- Comparison of renin-specific IgG and antibody fragments in studies of blood pressure regulation. (1984) (13)
- Immunofluorescence studies of florid rheumatic Aschoff lesions. (1986) (13)
- Inactive renin--"through a glass darkly". (1979) (13)
- Antibodies as models for rational drug design. (1983) (13)
- Antibody Targeting as a Thrombolytic Strategy (1992) (12)
- Characterization of five epitopes of human renin from a computer model. (1988) (12)
- Diversity among rabbit antibody light chain amino terminal sequences. (1976) (12)
- Activated platelets form protected zones of adhesion on fibrinogen and fibronectin-coated surfaces (1993) (12)
- Studies on antigen conformation during antibody purification. (1963) (12)
- Endothelin to the rescue? (1994) (12)
- Transformation by simian virus 40 of spleen cells from a hyperimmune rabbit: demonstration of production of specific antibody to the immunizing antigen. (1974) (12)
- The characterization of low renin hypertension by plasma renin activity and plasma aldosterone concentration. (1978) (12)
- Future directions in plasminogen activator therapy (1990) (12)
- Isolation of a renal thiol protease that activates inactive plasma renin. (1979) (11)
- Modification of monoclonal antimyosin antibody: enhanced specificity of localization and scintigraphic visualization in acute experimental myocardial infarction. (1989) (11)
- Characterization of Antibodies to Canine Renal Renin: Studies of Interspecies Homology of Renin Using Antibodies as Probe (1982) (11)
- Reduced serum digoxin levels in patients with malabsorption syndromes (1970) (11)
- A protein sequencing device of simple construction. (1970) (10)
- Quantitative removal of hepatitis B viral antigens from serum by a monoclonal IgM coupled to a biocompatible solid-phase support. (1983) (10)
- Immunological probes in cardiovascular disease. (1982) (10)
- Volume as a determinant of plasma aldosterone in anephric man. (1978) (10)
- Acceleration of plasma clot lysis by an antibody to alpha 2-antiplasmin. (1988) (9)
- Purification, specificity, and hypervariable region sequence of anti-pneumococcal polysaccharide antibodies elicited in a single rabbit. (1976) (9)
- Antibody-enhanced thrombolysis: capture of tissue plasminogen activator by a bispecific antibody and direct targeting by an antifibrin-tissue plasminogen activator conjugate in vivo. (1987) (9)
- Synthesis of a cyclic fibrin-like peptide and its analysis by fast atom bombardment mass spectrometry. (2009) (8)
- A monoclonal antibody specific for the carboxy-terminus of angiotensin II. (1984) (8)
- Hypertension--where do we go from here? (1985) (8)
- R-PEP-27, a potent renin inhibitor, decreases plasma angiotensin II and blood pressure in normal volunteers. (1994) (8)
- Erratum: Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells (The Journal of Biological Chemistry (1998) 273 (4400-4405)) (1998) (8)
- Amino acid sequence of normal (microheterogeneous) porcine immunoglobulin lambda chains. (1977) (8)
- Characterization of the heavy and light chain immunoglobulin variable region genes used in a set of anti-digoxin antibodies. (1989) (8)
- Binding of immunogenic peptides to Ia histocompatibility molecules. 1985. (2005) (7)
- Attachment of an antifibrin antibody to the amino terminus of tissue-type plasminogen activator impairs stimulation by Fibrin (1994) (7)
- Synthetic peptide immunogens for the development of a cardiac myosin light chain-1 specific radioimmunoassay. (1993) (7)
- Purification of renin: a review. (1977) (7)
- ANTIBODY TARGETED FIBRINOLYSIS (1987) (7)
- Antibodies to relatively homogeneous haptens: the temporal pattern of their antigen-binding energies. (1967) (7)
- Use of fab fragments of digoxin-specific antibodies in the therapy of massive digoxin poisoning. (1985) (7)
- THE RELATIONSHIP OF THE THREE DIMENSIONAL CONFORMATION OF PROTEINS TO THEIR ANTIGENIC SPECIFICITY (1964) (7)
- Angiotensin-converting enzyme and lipoprotein(a) as risk factors for myocardial infarction. (1995) (7)
- Antibodies to the alpha 1- and alpha 2-selective antagonists prazosin and yohimbine as probes of the alpha-adrenergic binding sites. (1982) (7)
- Isolation of an active variable-domain fragment from a homogeneous rabbit antibody heavy chain. Physiochemical and immunological properties. (1978) (7)
- Antibodies of restricted heterogeneity directed against the cardiac glycoside digoxin. (1978) (6)
- An overview of the 1996 Keystone meeting. Exploring and exploiting antibody and Ig superfamily combining sites. (1996) (6)
- A method for obtaining large variable-region peptides from rabbit light chains. (1972) (6)
- Quantifying cell death in the myocardium: myosin specific antibody in the evaluation of membrane defects. (1985) (6)
- Experimental and clinical studies with converting enzyme inhibitor. (1976) (6)
- Digoxin-specific antibody treatment of digitalis toxicity: Update (1986) (6)
- Can plasminogen activators be improved? (1990) (6)
- Detection of early necrosis in a canine model of low flow myocardial ischemia using 125I-antimyosin (Fab')2. (1987) (5)
- Imaging necrotic myocardium: detection with 99mTc-pyrophosphate and radiolabeled antimyosin. (1989) (5)
- A monoclonal antibody specific for the amino terminal sequence of human prorenin identifies a common epitope on renal and amniotic fluid inactive renins. (1986) (5)
- DETECTION BY RADIOLABELED ANTICARDIAC MYOSIN (FAB')2 (1983) (5)
- Characteristics of antibody to a limited antigenic stimulus. (1969) (5)
- The role of specific genes in transplant arteriosclerosis: studies in mutant mice. (1997) (5)
- Will renin inhibitors influence decision-making in antihypertensive therapy? (1985) (5)
- Treatment of severe digoxin toxicity with digoxin-specific antibodies: a case report. (1983) (5)
- Exploring and exploiting the antibody and Ig superfamily combining sites (1996) (5)
- Competitive inhibitors of renin. A review. (1976) (5)
- Renin in differential diagnosis of hypertension. (1971) (5)
- Diagnosis of Acute Myocarditis with Radiolabeled Monoclonal Antimyosin Antibody: Immunoscintigraphic Evaluation (1988) (5)
- Light chain variable region sequence of rabbit antipneumococcal type III polysaccharide antibody 3368. (1978) (5)
- In-111 labeled monoclonal anti-(fibrin-specific) antibody: Detection of pulmonary emboli (1985) (5)
- Corrigendum: Structure of antibody hypervariable loops reproduced by a conformational search algorithm (1988) (5)
- Physiological Receptors as Physicochemical Entities (1973) (5)
- Purifying antibody-plasminogen activator conjugates. (1992) (5)
- Importance of experimental models in study of thrombosis and thrombolysis. (1991) (4)
- Antibodies in cardiovascular diagnosis and therapy. (1986) (4)
- Study of the Antigenic Determinants of Human Renin (1986) (4)
- Antibodies to the Alpha1 and Alpha2‐Selective Antagonists Prazosin and Yohimbine as Probes of the Alpha‐Adrenergic Binding Sites (1982) (4)
- [Treatment of massive digitalis poisoning (20 mg of digitoxin) with anti-digoxin antibody fragments (Fab)]. (1980) (4)
- Dissociation of renin--aldosterone and renal prostaglandin E during volume expansion induced by immersion in normal man. (1980) (4)
- Antimyosin scintigraphy in myocarditis: Evaluation of diagnostic methodology (1991) (4)
- Degradation of E 2 A Proteins through a Ubiquitin-conjugating Enzyme , UbcE 2 (1997) (4)
- Scientific American: Molecular Cardiovascular Medicine (1995) (4)
- A rapid and efficient procedure for the removal of nonviable cells from suspension culture of lymphoid cell lines. (1980) (4)
- Mono clonal antibodies to tetanus toxin produced by clones of murine hybridomas (1980) (4)
- Antigen binding molecules : antibodies and T-cell receptors (1996) (4)
- Antibody-targeted thrombolytic agents. (1990) (4)
- Monoclonal antibodies directed against human myoglobin: characterization and application in a bideterminant radioimmunoassay. (1981) (4)
- Preparation of an active Fd fragment by cyanogen bromide cleavage of an IgG heavy chain from a homogeneous rabbit antibody. (1978) (4)
- Isolation of an active heavy-chain variable domain from a homogeneous rabbit antibody by cathepsin B digestion of the aminoethylated heavy chain. (1980) (4)
- Characterization of an angiotensin binding site in rabbit renomedullary interstitial cells in tissue culture: correlation with prostaglandin biosynthesis. (1979) (4)
- Monoclonal antibodies as molecular probes to study structural heterogeneity between human and animal renins and other aspartyl proteinases. (1986) (3)
- Defining the physiologic and pathophysiologic roles of renin: the role of specific inhibitors. (1985) (3)
- RESTRICTED CLONAL RESPONSES: A TOOL IN UNDERSTANDING ANTIBODY SPECIFICITY (1975) (3)
- Targeting of single-chain urokinase plasminogen activator by conjugation to an antiplatelet antibody results in enhanced clot lysis. (1991) (3)
- Design of potent substrate-analogue inhibitors of canine renin. (2009) (3)
- Enhancing specificity and stability of targeted liposomes by coincorporation of sialoglycoprotein and antibody on liposomes (1983) (3)
- Hybrid molecules: insights into plasminogen activator function. (1991) (3)
- Studies on two novel angiotensin II actions. (1982) (3)
- Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. (1996) (3)
- Inhibitors of renin: present and future. (1983) (3)
- Inhibition of Clot-Bound a2-Antiplasmin Enhances In Vivo Thrombolysis (2005) (3)
- Digoxin toxicity in a premature infant: Treatment with Fab fragments of digoxin-specific antibodies (2005) (3)
- Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody. (1989) (3)
- Anti-Alprenolol Antibodies in the Rabbit (3)
- A Radio-Immunoassay for Bradykinin (1966) (3)
- Infarct size after reperfusion by simultaneous intracoronary In-111-monoclonal antimyosin and Tc-99mPyrophosphate: Comparison by gamma scintigraphy (1984) (2)
- Renin and vascular homeostasis during anesthesia. (1979) (2)
- Increasing selectivity of plasminogen activators with antibodies. (1988) (2)
- Position Paper: New Approaches to Renin System Blockade (1981) (2)
- Monoclonal antibodies as physiologic probes. (1983) (2)
- Can a viral serine proteinase inhibitor prevent postangioplasty restenosis? (1996) (2)
- /sup 99m/Tc labeling of antibodies to cardiac myosin Fab and to human fibrinogen (1982) (2)
- Evolution of the Immune Response to Type III and VIII Pneumococcal Polysaccharides (1973) (2)
- The renin-angiotensin system in curable hypertension. (1969) (2)
- Isolation and characterization of an active variable domain from a homogeneous rabbit antibody light chain. (1979) (2)
- Immunologic approaches to the inhibition of renin and the adrenergic system. (1983) (2)
- The Application of Antibody to the Measurement of Substances of Physiological and Pharmacological Interest (1974) (2)
- Cellular hypersensitivity: the production of antibody by cultures of lymphocytes producing macrophage inhibitory factor. (1972) (2)
- Immunoaffinity chromatography of canine high-molecular-weight renin: partial purification and characterization. (1983) (2)
- New fibrinolytic agents — Future developments (1995) (2)
- Sites and Mechanisms of the Conversion of Angiotensin I to II (1972) (2)
- Hypertension in a 74-Year-Old Man with Hydronephrosis and Coronary Disease (2)
- Antifibrin-urokinase complex (1986) (2)
- Monoclonal antibodies specific for human renin. (1984) (2)
- Immunological aspects of toxicology--a workshop. (1982) (2)
- Production and characterization of human renin antibodies prepared with synthetic immunogens. (1987) (2)
- Studies of the three-dimensional structure of human renin and its inhibitors. (1984) (2)
- Recognition of peptide orientation: studies with angiotensin II in the guinea-pig. (1985) (2)
- Biologic Effects of Specific Antibodies in Reversing the Pharmacologic and Toxic Effects of Digoxin (1978) (2)
- Combining Site Specificity and Idiotypy (1984) (2)
- 76 Reduced transplant arteriosclerosis in plasminogen deficient mice (1997) (1)
- RENIN IN ACUTE POSTURAL HOMEOSTASIS in postural hypotension (1)
- Synthesis of renin inhibitors. A review. (2009) (1)
- PRODUCTION AND CHARACTERIZATION OF ANTIBODIES ELICITED BY DIFFERENT ALDOSTERONE-PROTEIN CONJUGATES (1972) (1)
- The role of renin in the control of the circulation and in hypertensive disease (1979) (1)
- Biosynthesis of intrinsically labeled antibodies in vitro. (1966) (1)
- Molecular mechanisms that control renin secretion. (1985) (1)
- Radioiodination and quality control of human thyrotropin for radioimmunoassay (1995) (1)
- The impact of biotechnology on advances in cardiovascular medicine. (1993) (1)
- The Fifth Volhard Lecture. Specific inhibitors of renin. (1980) (1)
- Antibody-targeted Plasminogen Activators (1988) (1)
- Insights Gained From the Study of Homogeneous Rabbit Antibodies (1979) (1)
- Hybridoma antibodies to the cardiac glycoside digoxin. Abstr. (1980) (1)
- Conversion of Angiotensin I to II In Vivo and In Vitro (1972) (1)
- The role of antibodies and physiological receptors in cardiovascular diagnosis, therapy, and research. (1973) (1)
- Antibodies from Escherichia coli (2001) (1)
- ANTIBODIES AS IN-VIVO DIAGNOSTIC AND THERAPEUTIC AGENTS (1983) (1)
- Class 1 major histocompatibility antigen modified with monomethoxy polyethylene glycol prolongs survival of cardiac allografts in mice (1991) (0)
- Renin inhibitors. (1986) (0)
- Thrombus-Targeting of Plasminogen Activators (2001) (0)
- [New findings on the specifity of aldosterone antibodies]. (1972) (0)
- Mono clonal antibodies to human cardiac myosin light chains potential for improvement of a radio immunometric assay for myo cardial infarction (1979) (0)
- Renin inhibitors. (1984) (0)
- From Molecular Biology to Antihypertensive Drugs: Current Research on Renin Inhibitors (1984) (0)
- Improving on nature: antibody-targeted enzymes. (1989) (0)
- Modification of monoclonal antibodies by polymers possessing chelating properties (1986) (0)
- The Practice of cardiology (2013) (0)
- CIBA Award for Hypertension Research (1990) (0)
- The importance of the renin-angiotensin system in normal cardiovascular homeostasis (1975) (0)
- [Production and characterization of human antirenin antibodies prepared with synthetic immunogens]. (1988) (0)
- Homogeneous Antibody and Myeloma Proteins with Antibody Activity (1971) (0)
- Are inactive renins in plasma and kidney related to prorenin? (1982) (0)
- Renin inhibitors. (1978) (0)
- [Increased thrombolysis and decreased platelet aggregation with an anti-GPIIb/IIIa antibody urokinase hybrid molecule (7E3-UK)]. (1991) (0)
- CHAPTER 17 – The Antibody Combining Site: A Basis for a New Pharmacology (1984) (0)
- Comment Can Plasminogen Activators Be Improved ? (2005) (0)
- The 126 KD Phosphoprotein of Human Breast Carcinoma Cell Surface (1984) (0)
- A sequence-dependent monoclonal antibody specific for single-chain urokinase. (1988) (0)
- Antibody-Mediated Thrombolysis: Promise and Problems (1990) (0)
- E2A-BP, A protein binding to E12/E47, inhibits differentiation of myoblasts (1996) (0)
- Cardiac physiology. Endothelin to the rescue? (1994) (0)
- Competitive inhibitors of renin. (1973) (0)
- Antibody-Enzyme Fusion Proteins and Bispecific Antibodies (1994) (0)
- Accelerating the lysis of clots. (1989) (0)
- Arrest of endotoxin-induced hypotension by transforming growth factor , 31 ( septic shock / inducible nitric oxide synthase / selective inhibition / vascular smooth muscle cells ) (2005) (0)
- Zero gravity and cardiovascular homeostasis. The relationship between endogenous hyperprolactinemia and plasma aldosterone. Summary report, 1 February 1977--31 January 1978 (1978) (0)
- Herman Kalckar: An Appreciation (1984) (0)
- Erratum: Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells (Journal of Biological Chemistry (1996) 271 (10194- 10199)) (1998) (0)
- Erratum: Amplification of CD44 and CD44-v6 from RASMC (Journal of Clinical Investigation (1 February 1996) 97:3 (597)) (1996) (0)
- Monoclonal Antibodies as Diagnostic and Therapeutic Cardiovascular Agents (1986) (0)
- Radioactive iodine treatment of euthyroid cardiac disease. A seventeen year follow-up. (1970) (0)
- Primary structure of a mouse anti-digoxin hybridoma antibody. Abstr. (1981) (0)
- Synthesis of renin inhibitors. (1973) (0)
- Role of Renin in the Control of the Circulation in Hypertensive Disease and in Heart Failure (1982) (0)
- The Cell membrane : its role in interaction with the outside world : a volume in honor of Professor Herman Kalckar on his seventy-fifth birthday (1984) (0)
- Kidney and cardiovascular regulation (1983) (0)
- Clinical Investigation Treatment of 150 Cases of Life-Threatening Digitalis Intoxication With Digoxin-Specific Fab Antibody Fragments (2005) (0)
- Accelerated Hypertension in a 64-Year-Old White Woman (2005) (0)
- Variable region sequences of two antipneumococcal antibody light chains (1975) (0)
- Immunologic Assay of Biologically Active Materials (1971) (0)
- Clinical Conference Pseudopheochromocytoma Principal (2005) (0)
- SULFUR PROTECTION WITH THE 3-NITRO-2-PYRIDINESULFENYL GROUP IN SOLID-PHASE PEPTIDE SYNTHESIS. SYNTHESIS OF LYSINE8-VASOPRESSIN (1982) (0)
- nucleic acids inhibit the formation of atherosclerotic sore by AFABP antisense (2000) (0)
- IR spectroscopic study of the adsorption of hydrocarbons on oxide catalysts. XI. Adsorbed forms and stabilization centers of propylene and ethylene on NiO-MgO-MoO/sub 3/ and CoO-MgO-MoO/sub 3/ (1982) (0)
- [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo]. (1990) (0)
- Thrombolysis: Basic Contributions and Clinical Progress (1991) (0)
- 26-10 Fab-digoxin complex : Affinity and specifilcity due to surface complementarity ( x-ray crystallography / antibody-antigen complex / antibodies / anti-digoxin ) (0)
- PREDICTION OF HUMAN RENIN EPITOPES USING A NEW COMPUTER ALGORITHM (1987) (0)
- A Note of Thanks (1988) (0)
- Editorial Comment Can Plasminogen Activators Be Improved? (2005) (0)
- [Direct radioimmunologic demonstration of plasma aldosterone]. (1972) (0)
- The CIBA award for 1985. A full circle in two generations. (1986) (0)
- Cytokine regulation of CD44 gene expression in vascular smooth muscle cells (1996) (0)
- X-ray crystallography of FAB fragments of anti-digoxin and anti-arsonate antibodies (1984) (0)
- Case 31-1966 (1966) (0)
- Development of Sensitive and Direct Methods for Measuring Plasma Aldosterone and Catecholamine Concentrations (1972) (0)
- The separation of fully reduced and alkylated, variable and constant regions from an antipolysaccharide antibody light chain by semi-preparative polyacrylamide gel electrophoresis. (1973) (0)
- The Practice of cardiology : the medical and surgical cardiac units at the Massachusetts General Hospital (1980) (0)
- MONOCLONAL ANTIBODIES IN CARDIOLOGY (1986) (0)
- WHEN ECTO AND ENDOBIOLOGY MERGE: MONITORING ISCHEMIC CELL DEATH (1984) (0)
- The Antibody Combining Site (1985) (0)
- Fibrin - specific monoclonal antibodies are elicited by immunization with a synthetic fibrin-like peptide (1985) (0)
- Studies with Anti-Pneumococcal Antibodies (1971) (0)
- Immunologic basis of transplant-associated arteriosclerosis (mutant mice/homologous recombination/immune deficiency/allogeneic vascular transplantation) (2005) (0)
- New Insights into the Medical Management of Primary Aldosteronism (2005) (0)
- Studies in Transplant Arteriosclerosis Using Gene Deletions (1998) (0)
- Human Vasoregulation by Renin, Angiotensin, and Aldosterone (1971) (0)
- The synthesis of specific competitive inhibitors of renin. (1973) (0)
- Impaired transplant atherosclerosis in plasminogen deficient mice (1997) (0)
- Potential roles of tyrosine phosphatase mkp-1 in the proliferation of rat vascular smooth muscle cells (1996) (0)
- Tumor necrosis factor-α (TNF-α) decreases expression of the vascular endothelial growth factor (VEGF) receptor flk-1 (1996) (0)
- Infarct size imaging by Tc-99m labelled antimyosin antibody: A powerful acute myocardial infarction prognostic tool (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edgar Haber?
Edgar Haber is affiliated with the following schools:
